323 related articles for article (PubMed ID: 10914792)
1. Metabolic diseases and their possible link to risk indicators of periodontitis.
Noack B; Jachmann I; Roscher S; Sieber L; Kopprasch S; Lück C; Hanefeld M; Hoffmann T
J Periodontol; 2000 Jun; 71(6):898-903. PubMed ID: 10914792
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Prevotella intermedia in progressive adult periodontitis.
López NJ
J Periodontol; 2000 Jun; 71(6):948-54. PubMed ID: 10914798
[TBL] [Abstract][Full Text] [Related]
3. Subgingival microflora and antibody responses against periodontal bacteria of young Japanese patients with type 1 diabetes mellitus.
Takahashi K; Nishimura F; Kurihara M; Iwamoto Y; Takashiba S; Miyata T; Murayama Y
J Int Acad Periodontol; 2001 Oct; 3(4):104-11. PubMed ID: 12666949
[TBL] [Abstract][Full Text] [Related]
4. Smoking affects the subgingival microflora in periodontitis.
van Winkelhoff AJ; Bosch-Tijhof CJ; Winkel EG; van der Reijden WA
J Periodontol; 2001 May; 72(5):666-71. PubMed ID: 11394403
[TBL] [Abstract][Full Text] [Related]
5. Periodontal infections contribute to elevated systemic C-reactive protein level.
Noack B; Genco RJ; Trevisan M; Grossi S; Zambon JJ; De Nardin E
J Periodontol; 2001 Sep; 72(9):1221-7. PubMed ID: 11577954
[TBL] [Abstract][Full Text] [Related]
6. Diabetes and periodontal disease: a case-control study.
Campus G; Salem A; Uzzau S; Baldoni E; Tonolo G
J Periodontol; 2005 Mar; 76(3):418-25. PubMed ID: 15857077
[TBL] [Abstract][Full Text] [Related]
7. Effect of initial therapy on dynamics of immunogloblin G levels to some periodontopathic bacteria in serum and gingival crevicular fluid.
Hosaka Y; Saito A; Nakagawa T; Seida K; Yamada S; Okuda K
Bull Tokyo Dent Coll; 1994 Nov; 35(4):207-16. PubMed ID: 8689734
[TBL] [Abstract][Full Text] [Related]
8. "Checkerboard" assessments of periodontal microbiota and serum antibody responses: a case-control study.
Papapanou PN; Neiderud AM; Papadimitriou A; Sandros J; Dahlén G
J Periodontol; 2000 Jun; 71(6):885-97. PubMed ID: 10914791
[TBL] [Abstract][Full Text] [Related]
9. Clinical periodontal and microbiologic parameters in patients with acute myocardial infarction.
Stein JM; Kuch B; Conrads G; Fickl S; Chrobot J; Schulz S; Ocklenburg C; Smeets R
J Periodontol; 2009 Oct; 80(10):1581-9. PubMed ID: 19792846
[TBL] [Abstract][Full Text] [Related]
10. Clinical responses to mechanical periodontal treatment in Chinese chronic periodontitis patients with and without Actinobacillus actinomycetemcomitans.
Tong KS; Zee KY; Lee DH; Corbet EF
J Periodontol; 2003 Nov; 74(11):1582-8. PubMed ID: 14682654
[TBL] [Abstract][Full Text] [Related]
11. Clinical and microbiological associations in chronic periodontitis.
Nogueira Moreira A; Chiappe V; Fernández Caniggia L; Alonso C; Piovano S
Acta Odontol Latinoam; 2004; 17(1-2):15-21. PubMed ID: 15584257
[TBL] [Abstract][Full Text] [Related]
12. Relationship between serum antibody levels and subgingival colonization of Porphyromonas gingivalis in patients with various types of periodontitis.
Kojima T; Yano K; Ishikawa I
J Periodontol; 1997 Jul; 68(7):618-25. PubMed ID: 9249632
[TBL] [Abstract][Full Text] [Related]
13. Subgingival microbiota of chilean patients with chronic periodontitis.
López NJ; Socransky SS; Da Silva I; Japlit MR; Haffajee AD
J Periodontol; 2004 May; 75(5):717-25. PubMed ID: 15212354
[TBL] [Abstract][Full Text] [Related]
14. Full-mouth ultrasonic debridement associated with amoxicillin and metronidazole in the treatment of severe chronic periodontitis.
Ribeiro Edel P; Bittencourt S; Zanin IC; Bovi Ambrosano GM; Sallum EA; Nociti FH; Gonçalves RB; Casati MZ
J Periodontol; 2009 Aug; 80(8):1254-64. PubMed ID: 19656025
[TBL] [Abstract][Full Text] [Related]
15. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis subgingival presence, species-specific serum immunoglobulin G antibody levels, and periodontitis disease recurrence.
Rams TE; Listgarten MA; Slots J
J Periodontal Res; 2006 Jun; 41(3):228-34. PubMed ID: 16677293
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Bacteroides forsythus in humans 1 year after 4 randomized treatment modalities.
Shiloah J; Patters MR; Dean JW; Bland P; Toledo G
J Periodontol; 1998 Dec; 69(12):1364-72. PubMed ID: 9926766
[TBL] [Abstract][Full Text] [Related]
17. Persistence patterns of Porphyromonas gingivalis, Prevotella intermedia/nigrescens, and Actinobacillus actinomyetemcomitans after mechanical therapy of periodontal disease.
Mombelli A; Schmid B; Rutar A; Lang NP
J Periodontol; 2000 Jan; 71(1):14-21. PubMed ID: 10695934
[TBL] [Abstract][Full Text] [Related]
18. Clinical and microbiologic follow-up evaluations after non-surgical periodontal treatment with erbium:YAG laser and scaling and root planing.
Lopes BM; Theodoro LH; Melo RF; Thompson GM; Marcantonio RA
J Periodontol; 2010 May; 81(5):682-91. PubMed ID: 20429647
[TBL] [Abstract][Full Text] [Related]
19. Clinical and microbiological status of osseointegrated implants.
George K; Zafiropoulos GG; Murat Y; Hubertus S; Nisengard RJ
J Periodontol; 1994 Aug; 65(8):766-70. PubMed ID: 7965553
[TBL] [Abstract][Full Text] [Related]
20. A 2-step non-surgical procedure and systemic antibiotics in the treatment of rapidly progressive periodontitis.
Sigusch B; Beier M; Klinger G; Pfister W; Glockmann E
J Periodontol; 2001 Mar; 72(3):275-83. PubMed ID: 11327054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
